Word

BRYLZ

Status

Pending

Status Code

730

Status Date

Monday, December 18, 2023

Serial Number

97479522

Mark Type

4000

Filing Date

Tuesday, June 28, 2022

Published for Opposition

Tuesday, May 23, 2023

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events

Dec 20, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 18, 2023

Sou Extension 1 Granted

Dec 18, 2023

Sou Extension 1 Filed

Dec 18, 2023

Sou Teas Extension Received

Jul 18, 2023

Noa E-Mailed - Sou Required From Applicant

May 23, 2023

Official Gazette Publication Confirmation E-Mailed

May 23, 2023

Published For Opposition

May 3, 2023

Notification Of Notice Of Publication E-Mailed

Apr 14, 2023

Approved For Pub - Principal Register

Apr 12, 2023

Assigned To Examiner

Jul 18, 2022

New Application Office Supplied Data Entered

Jul 1, 2022

New Application Entered